Intended for healthcare professionals


HRT raises risk of rare, treatable breast cancer

BMJ 1999; 318 doi: (Published 19 June 1999) Cite this as: BMJ 1999;318:1645
  1. Scott Gottlieb
  1. New York

    A study of women using hormone replacement therapy after menopause found that the treatment does not increase the risk of highly malignant breast cancer but does raise the risk of some uncommonforms of the disease that are slow growing and highly treatable. Some previous studies have shown that women who take oestrogen after menopause are more likely to …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription